Location
East Irvine, CA, United States
Posted on
Feb 28, 2022
Profile
nnn
Improving quality-of-life through innovations in urology.
**MEMBERS ONLY**SIGN UP NOW***.. is a biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions and improving the way providers and their patients confront urologic diseases that are difficult to treat.
Every employee at Urovant plays an integral role to our success. We are ambitious in our approach to improving outcomes for the patients and healthcare providers we serve. Our fast-paced environment rewards strategic decision-making and collaboration, giving team members opportunities to grow beyond their expertise.
Urovant's lead product, GEMTESA® (vibegron), is an oral, once-daily (75 mg) small molecule beta-3 agonist approved by the U.S. FDA in December 2020 for the treatment of adult patients with overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency. GEMTESA® is also being evaluated for the treatment of OAB in men with benign prostatic hyperplasia (OAB BPH).
Urovant's second product candidate, URO-902, is a novel gene therapy being developed for patients with OAB who have failed oral pharmacologic therapy.
nnnnnnnnPosition Descriptionnnn
nnnnReporting to the SVP, CMC Development and Technical Operations, the Vice President, CMC Development, will be responsible for providing strategic direction, technical leadership and operational execution for ensuring successful CMC development activities and clinical manufacturing for all small molecule and biologics programs at Urovant. Responsible for all phases of drug product development and will support the successful transfer into commercial manufacturing. This position partners with Urovant CMC / Technical functions and global CMO's partners to provide technical leadership, strategic direction, risk management, and oversight for successful planning and execution across all supporting functions. We are looking for an experienced leader who will help us build an organization fit for growth to successfully deliver innovative therapies to the patients we serve. This person will also build relationships and partner with counterparts at our parent companies, Sumitomo Dainippon Pharma Company, LTD. and Sumitovant Biopharma LTD, to establish a strong collaborative culture that leverages operational synergies and expertise effectively from each other when appropriate. They will also provide guidance to product and business development teams during review of potential new drug product candidates and partnerships.
nnnnnnnnKey Duties and Responsibilitiesnnn
nnnnnnnnEducation and Experiencennn
nnnnnnnnEssential Skills and Abilitiesnnn
nnnnTo ensure the health and safety of our workforce while doing our part to protect those around us, Urovant Sciences is requiring proof of full COVID vaccination for US and Global employees as a condition of employment to the extent permissible under federal and state laws and subject to legally-recognized accommodations.
#LI-hybrid
#LI-BM1
nnn,identifier:{name:**MEMBERS ONLY**SIGN UP NOW***.,value:2021-1474,@type:PropertyValue},datePosted:2022-03-01T05:53:15 00:00,validThrough:2022-03-31T04:00:00 00:00,employmentType:FULL_TIME,hiringOrganization:{name:**MEMBERS ONLY**SIGN UP NOW***.,@id:1890805,url:****CA,address:{addressCountry:US,addressLocality:East Irvine,addressRegion:California,@type:PostalAddress},@type:place},industry:Science/R&D, CMC,workHours:Full time,educationRequirements:Masters Degree/MBA,@type:JobPosting,@context:****Company info
Sign Up Now - CLevelCrossing.com